0001144204-14-016518.txt : 20140318
0001144204-14-016518.hdr.sgml : 20140318
20140318205134
ACCESSION NUMBER: 0001144204-14-016518
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20140312
FILED AS OF DATE: 20140318
DATE AS OF CHANGE: 20140318
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ANI PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001023024
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 582301143
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 210 MAIN STREET WEST
CITY: BAUDETTE
STATE: MN
ZIP: 56623
BUSINESS PHONE: 2186343500
MAIL ADDRESS:
STREET 1: 210 MAIN STREET WEST
CITY: BAUDETTE
STATE: MN
ZIP: 56623
FORMER COMPANY:
FORMER CONFORMED NAME: BIOSANTE PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19991228
FORMER COMPANY:
FORMER CONFORMED NAME: BEN ABRAHAM TECHNOLOGIES INC
DATE OF NAME CHANGE: 19991027
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Brown Robert E. JR
CENTRAL INDEX KEY: 0001579672
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-31812
FILM NUMBER: 14702515
BUSINESS ADDRESS:
BUSINESS PHONE: 218-634-3500
MAIL ADDRESS:
STREET 1: 210 MAIN STREET WEST
STREET 2: C/O BIOSANTE PHARMACEUTICALS, INC.
CITY: BAUDETTE
STATE: MN
ZIP: 56623
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Meridian Venture Partners II, Co.
CENTRAL INDEX KEY: 0001580169
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1213
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-31812
FILM NUMBER: 14702516
BUSINESS ADDRESS:
STREET 1: 259 N. RADNOR-CHESTER ROAD
STREET 2: SUITE 130
CITY: RADNOR
STATE: PA
ZIP: 19087
BUSINESS PHONE: 610-254-2999
MAIL ADDRESS:
STREET 1: 259 N. RADNOR-CHESTER ROAD
STREET 2: SUITE 130
CITY: RADNOR
STATE: PA
ZIP: 19087
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Meridian Venture Partners II GP, L.P.
CENTRAL INDEX KEY: 0001580170
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1213
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-31812
FILM NUMBER: 14702517
BUSINESS ADDRESS:
STREET 1: 259 N. RADNOR-CHESTER ROAD
STREET 2: SUITE 130
CITY: RADNOR
STATE: PA
ZIP: 19087
BUSINESS PHONE: 610-254-2999
MAIL ADDRESS:
STREET 1: 259 N. RADNOR-CHESTER ROAD
STREET 2: SUITE 130
CITY: RADNOR
STATE: PA
ZIP: 19087
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MERIDIAN VENTURE PARTNERS II LP
CENTRAL INDEX KEY: 0001109507
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-31812
FILM NUMBER: 14702518
BUSINESS ADDRESS:
STREET 1: 259 RADNOR CHESTER ROAD
STREET 2: SUITE 140
CITY: RADNOR
STATE: PA
ZIP: 19087
4/A
1
v372127_4a.xml
OWNERSHIP DOCUMENT
X0306
4/A
2014-03-12
2014-03-14
0
0001023024
ANI PHARMACEUTICALS INC
ANIP
0001109507
MERIDIAN VENTURE PARTNERS II LP
259 N. RADNOR-CHESTER ROAD
SUITE 130
RADNOR
PA
19087
0
0
1
0
0001580170
Meridian Venture Partners II GP, L.P.
259 N. RADNOR-CHESTER ROAD
SUITE 130
RADNOR
PA
19087
0
0
1
0
0001580169
Meridian Venture Partners II, Co.
259 N. RADNOR-CHESTER ROAD
SUITE 130
RADNOR
PA
19087
0
0
1
0
0001579672
Brown Robert E. JR
C/O ANI PHARMACEUTICALS, INC.
210 MAIN STREET WEST
BAUDETTE
MN
56623
1
0
0
0
Common Stock
2014-03-12
4
S
0
32802
33.61
D
2786942
D
Common Stock
2014-03-12
4
S
0
2517
34.33
D
2784425
D
Common Stock
2014-03-13
4
S
0
33514
31.05
D
2750911
D
Common Stock
2014-03-13
4
S
0
12138
32.53
D
2738773
D
Common Stock
2014-03-13
4
S
0
6752
33.31
D
2732021
D
On March 14, 2014, the reporting person filed a Form 4 that reported sales of the Issuer's securities, which Form 4 contained an inadvertent error in the amount of securities beneficially owned following the reported sales transaction. This Form 4 also corrects the method of reporting the prices of the securities sold.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.20 to $34.19 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold by the Reporting Person at each separate price on each date of sale.
Meridian Venture Partners II, Co. (MVP Corp.) is the general partner of Meridian Venture Partners II GP, L.P. (GP), the general partner of Meridian Venture Partners II, L.P. (MVP II). Robert E. Brown, Jr., a director of the issuer, is the President, sole stockholder and sole director of MVP Corp., as well as a limited partner of GP and one of two principals of MVP II.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.20 to $34.61 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold by the Reporting Person at each separate price on each date of sale.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.00 to $31.64 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold by the Reporting Person at each separate price on each date of sale.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.05 to $32.80 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold by the Reporting Person at each separate price on each date of sale.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.20 to $33.65 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold by the Reporting Person at each separate price on each date of sale.
/s/ Robert E. Brown, Jr.
2014-03-18